Biotech Values

[jq1234]

>> Targacept has reported 13 consecutive trial failures covering 6 distinct indications and 6 distinct drugs. Surely, a record in drug development futility that may never be matched.

Well, you have to give them credit for running randomized trials, mostly forced upon them by indications they chose to work on. To break their streak, they could have chosen to take one short cut by running one single arm trial that wouldn't be considered failure.